Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Federal Trade Commission
Medtronic
AstraZeneca
Cipla
Argus Health
Teva
Merck
Colorcon

Generated: October 19, 2018

DrugPatentWatch Database Preview

Dbl Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for DBL PHARMS, and what generic and branded alternatives to DBL PHARMS drugs are available?

DBL PHARMS has one approved drug.



Summary for Dbl Pharms
US Patents:0
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Dbl Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dbl Pharms METHOCARBAMOL methocarbamol TABLET;ORAL 203550-002 Feb 8, 2017 AA RX No No ➤ Sign Up ➤ Sign Up
Dbl Pharms METHOCARBAMOL methocarbamol TABLET;ORAL 203550-001 Feb 8, 2017 AA RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Deloitte
Covington
Accenture
Argus Health
Johnson and Johnson
Mallinckrodt
Merck
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.